Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02485977 · ClinicalTrials.gov registry record

Cardiac MRI in Pulmonary Hypertension

A clinical trial of Pulmonary Hypertension, sponsored by University of California, San Francisco.

Completed
Registry status
24
Enrollment target
1
Study location

NCT02485977: Completed study of Pulmonary Hypertension, sponsored by University of California, San Francisco.

NCT02485977 is a study of Pulmonary Hypertension that has completed, run by University of California, San Francisco. The registered enrollment target is 24 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02485977, a study of Pulmonary Hypertension, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this study is to evaluate agreement between cardiac MR parameters and well-established clinical and catheterization parameters of poor prognosis in patients with pulmonary hypertension. The identification of noninvasive cardiac MR techniques to evaluate myocardial disease in patients with pulmonary hypertension would be beneficial to society due to the potential to replace serial invasive cardiac catheterization procedures with a noninvasive imaging test.

Conditions Studied

Interventions

  • DEVICE Magnetic resonance Imaging

Study Locations (1)

California

  • UCSF Medical Center - San Francisco

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2015-07
Est. Completion 2017-06

What the finished NCT02485977 record still lists

NCT02485977 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Magnetic resonance Imaging is the first listed.

NCT02485977 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02485977 about?

NCT02485977 is a clinical study titled "Cardiac MRI in Pulmonary Hypertension". The overall goal of this study is to evaluate agreement between cardiac MR parameters and well-established clinical and catheterization parameters of poor prognosis in patients with pulmonary hypertension. The identification of noninvasive cardiac MR techniques to evaluate myocardial disease in pati...

What is the current status of trial NCT02485977?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2015-07. Estimated completion is 2017-06.

What conditions does trial NCT02485977 study?

This clinical trial studies the following conditions: Pulmonary Hypertension.

What interventions are being tested in trial NCT02485977?

The interventions under investigation include: Magnetic resonance Imaging (DEVICE).

Who is sponsoring clinical trial NCT02485977?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02485977 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02485977's enrollment target sits among peer trials

24 54th of 72 higher than 17 of 72 other Pulmonary Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02485977, the US trial registry maintained by the National Library of Medicine. NCT02485977 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.